Molecular mechanism of thrombin receptor-specific 33 kDa protein kinase
Molecular mechanism of thrombin receptor-specific 33 kDa protein kinase
批准号:
13680711
负责人:
IDO Masaru
金额:
$0.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Thrombin is a multifunctional serine protease that plays an important role in hemostasis and wound healing. Protease-activated receptor 1 (PAR1/ thrombin receptor) is a member of the G protein-coupled receptor (GPCR) containing seven transmembrane domains. Thrombin cleaves the receptor at the Arg41/Ser42 peptide bond and unmasks a tethered amino-terminal sequence beginning with the Ser-Phe-Leu-Leu-Arg-Asn (thrombin receptor agonist peptide/TRAP) ; subsequent binding of this ligand sequence to the body of the receptor is coupled with a transmembrane signaling mediated by G proteins. Phosphorylation of GPCR by G protein-coupled receptor kinases (GRKs) is thought to play a central role in receptor regulation. Recently, casein kinase I (CKI) was reported to phosphorylate GPCR. We previously identified a novel 33-kDa Ser/Thr protein kinase (PK33) in thrombin-stimulated platelets that participates in the phosphorylation of cytoplasmic tail of PAR-1. In the present study, we examined whether PK33 belongs to the same family of GRKs or CKI. PK33 was partially purified from thrombin-stimulated platelets through chromatography using HiTrap-DEAE, HiTrap-SP, HiTrap-Blue, and HiTrap-Heparin. Fractions after HiTrap-Heparin were examined by Western blotting using anti-GRK2, anti-GRK3, anti-GRK5 or anti-CKI antibody and in-gel renaturation protein kinase assay for PK33. GRK2, GRK3 and CKI were eluted in the HiTrap-Heparin-bound fractions differently from PK33. GRK5 did not bind to HiTrap-Heparin. The results of this study suggest that PK33 is a novel protein kinase distinct from GRK2, GRK3, GRK5 or CKI.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kume M, Hayashi T, Yuasa H, Tanaka H, Nishioka J, Ido M, Gabazza EC, Kawarada Y and Suzuki K: "Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats - a possible mechanism of intrasinusoidal microthro
Kume M、Hayashi T、Yuasa H、Tanaka H、Nishioka J、Ido M、Gabazza EC、Kawarada Y 和 Suzuki K:“细菌脂多糖降低大鼠窦内皮细胞中血栓调节蛋白的表达 - 窦内微血栓的可能机制
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu S, Gabazza EC, Taguchi O, Yasui H, Taguchi Y, Hayashi T, Ido M, Shimizu T, Nakagaki T, Kobayashi H, Fukudome K, Tsuneyoshi N, D'Alessandro-Gabazza CN, Izumizaki M, Iwase M, Homma I, Adachi Y and Suzuki K: "Activated Protein C Inhibits the Expressi
Shimizu S、Gabazza EC、田口 O、Yasui H、田口 Y、Hayashi T、Ido M、Shimizu T、Nakagaki T、Kobayashi H、Fukudome K、Tsuneyoshi N、DAlessandro-Gabazza CN、Izumizaki M、Iwase M、Homma
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ido, M.(7人略5人目): "Bacterial lipopolysaccharide decreases thrombomodulin expression on sinusoidal endothelial cells of rats, which may induce liver dysfunction via microthrombus formation in the sinusoids"J. Hepatol.. 38. 9-17 (2003)
Ido,M.(省略 7 人,第 5 人):“细菌脂多糖降低大鼠肝窦内皮细胞上的血栓调节蛋白表达,这可能通过肝窦中的微血栓形成诱导肝功能障碍”J. Hepatol.. 38. 9-17 (2003) )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Gabazza EC, Hayashi T, Ido M, Adachi Y and Suzuki K: "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism"Clin Sci. 102. 167-175 (2002)
Gabazza EC、Hayashi T、Ido M、Adachi Y 和 Suzuki K:“腺苷通过一氧化氮介导的机制抑制凝血酶诱导的内皮细胞上组织因子的表达”Clin Sci。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ido, M.(8人略3人目): "A pivotal role of rho GTPase in the regulation of morphology and function of dendritic cells"J Immunol. 167. 3585-3591 (2001)
Ido, M.(8 篇中的第 3 篇):“rho GTP 酶在树突状细胞形态和功能调节中的关键作用”J 免疫学杂志 167. 3585-3591 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Molecular mechanism of thrombin receptor pathway that mediated apoptosis in neural cells
-
批准号:10680605
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:1998
-
负责人:IDO Masaru
-
依托单位:
A novel serine/threonine kinase associated with thrombin receptor signaling in human platelet
-
批准号:08680680
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:IDO Masaru
-
依托单位:
Studies on the genetic analysis of a patient with protein C deficien
-
批准号:04671433
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:IDO Masaru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
D-serine 功能化神经肽自组装水凝胶设计及
脊髓损伤修复应用
-
批准号:Q24H090037
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周晓林
-
依托单位:
乳腺癌发生发展过程中巨噬细胞glucose-serine-glycine-1-carbon代谢异常对肿瘤恶性进展的影响及其分子机制的研究
-
批准号:81730077
-
项目类别:重点项目
-
资助金额:290.0万元
-
批准年份:2017
-
负责人:胡海
-
依托单位:
D-serine在癫痫发生中的作用机制
-
批准号:31401176
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2014
-
负责人:刘永红
-
依托单位:
D-serine在慢性脑低灌注致认知障碍中的作用研究
-
批准号:81360065
-
项目类别:地区科学基金项目
-
资助金额:48.0万元
-
批准年份:2013
-
负责人:王莲
-
依托单位:
神经元-胶质细胞交互调控D-serine在血管性痴呆(VD)模型中的作用及雌激素的干预研究
-
批准号:31171354
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:王瑞敏
-
依托单位:
三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
-
批准号:31040083
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:肖调义
-
依托单位: